免疫球蛋白预防性应用于放射性口腔黏膜炎的疗效 - Suppr | 超能文献

Efficacy of prophylactic application of immunoglobulins in radiation induced mucositis.

作者信息

Mose S, Adamietz I A, Saran F, Thilmann C, Heyd R, Böttcher H D

机构信息

Abteilung für Strahlentherapie und Onkologie, Zentrum der Radiologie, Johann-Wolfgang-Goethe-Universität, Frankfurt.

出版信息

Strahlenther Onkol. 1995 Jul;171(7):415-6.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Efficacy of prophylactic application of immunoglobulins in radiation induced mucositis.免疫球蛋白预防性应用于放射性口腔黏膜炎的疗效

Strahlenther Onkol. 1995 Jul;171(7):415-6.

2

Can prophylactic application of immunoglobulin decrease radiotherapy-induced oral mucositis?预防性应用免疫球蛋白能否降低放疗引起的口腔黏膜炎？

Am J Clin Oncol. 1997 Aug;20(4):407-11. doi: 10.1097/00000421-199708000-00018.

3

[Immunoglobulin for prevention of radiogenic mucositis].[用于预防放射性口腔黏膜炎的免疫球蛋白]

HNO. 1995 Jul;43(7):421-6.

4

[Prevention of radiochemotherapy-induced mucositis. Value of the prophylactic mouth rinsing with PVP-iodine solution].[预防放化疗引起的粘膜炎。聚维酮碘溶液预防性漱口的价值]

Strahlenther Onkol. 1998 Mar;174(3):149-55. doi: 10.1007/BF03038498.

5

The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).对头颈部晚期局部区域鳞状细胞癌（SCCHN）患者同步接受每周一次卡铂、紫杉醇和每日放疗（RT）时使用氨磷汀进行黏膜保护的评估。

Semin Oncol. 2004 Dec;31(6 Suppl 18):2-7. doi: 10.1053/j.seminoncol.2005.02.001.

6

Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.皮下注射氨磷汀在接受头颈部鳞状细胞癌综合治疗的患者中减轻辐射诱导毒性的疗效和安全性。

Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1361-8. doi: 10.1016/j.ijrobp.2007.05.052. Epub 2007 Sep 14.

7

[Cytoprotection with amifostine in radiotherapy or radio-chemotherapy of head and neck tumors].氨磷汀对头颈部肿瘤放疗或放化疗的细胞保护作用

Strahlenther Onkol. 1999 Nov;175 Suppl 4:30-3.

8

Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.局部应用粒细胞巨噬细胞集落刺激因子预防和治疗晚期头颈癌患者化疗及同步放化疗所致严重口腔黏膜炎的II期临床试验：有效性、安全性及成本评估

Oncol Rep. 2003 Jan-Feb;10(1):197-206.

9

[Radiation-induced mucositis and neutrophil granulocytes in oral mucosa].[放射性口腔黏膜炎与口腔黏膜中的中性粒细胞]

Strahlenther Onkol. 2003 Oct;179(10):667-72. doi: 10.1007/s00066-003-1121-1.

10

[Tranexamic acid in the prevention of oropharyngeal radiomucositis].氨甲环酸预防口咽放射性黏膜炎

Radiol Med. 1983 May;69(5):325-6.

引用本文的文献

1

[Prevention of radiochemotherapy-induced mucositis. Value of the prophylactic mouth rinsing with PVP-iodine solution].[预防放化疗引起的粘膜炎。聚维酮碘溶液预防性漱口的价值]

Strahlenther Onkol. 1998 Mar;174(3):149-55. doi: 10.1007/BF03038498.

2

[The therapeutic management of radiogenic oral mucositis].[放射性口腔黏膜炎的治疗管理]

Strahlenther Onkol. 1997 Apr;173(4):183-92. doi: 10.1007/BF03039287.